Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Tatsuya Yagi"'
Autor:
Takuya Daicho, Tatsuya Yagi, Yohei Abe, Meiko Ohara, Tetsuro Marunouchi, Satoshi Takeo, Kouichi Tanonaka
Publikováno v:
Journal of Pharmacological Sciences, Vol 111, Iss 1, Pp 33-43 (2009)
The present study was undertaken to explore the possible involvement of alterations in the mitochondrial energy-producing ability in the development of the right ventricular failure in monocrotaline-administered rats. The rats at the 6th week after s
Externí odkaz:
https://doaj.org/article/f95335e192884dd4bc8e90d8aeff2ad8
Publikováno v:
Journal of Infection and Chemotherapy. 29:119-125
Plasma daptomycin has not been fully characterized in diabetic and obese patients. This study aimed to evaluate the associations of plasma daptomycin with glycation of serum albumin and obesity.Infectious patients (n = 70) receiving intravenous dapto
Autor:
Tatsuya Yagi, Buster Mannheimer, Johan Reutfors, Johan Ursing, Diego Hernan Giunta, Helle Kieler, Marie Linder
Publikováno v:
British journal of clinical pharmacologyREFERENCES.
Fluoroquinolones and macrolides may, due to a potential drug-drug interaction, increase the concentration of any concomitantly administered direct oral anticoagulant (DOAC) and thereby increase the risk of severe bleeding. However, clinical evidence
Publikováno v:
Annals of Pharmacotherapy. 55:157-164
Background: The difference in type of antibiotics and susceptibility of Bacteroides fragilis to antibiotics may influence warfarin anticoagulation. However, these influences have not been clarified in clinical settings. Objectives: This study aimed t
Publikováno v:
Therapeutic Drug Monitoring. 41:591-597
Patients with cancer receiving pregabalin potentially have a high incidence of central nervous system (CNS) symptoms. The purpose of this study was to explore clinical factors influencing the incidence of CNS symptoms, including plasma pregabalin exp
Autor:
Tatsuya Yagi
Publikováno v:
Annals of Pharmacotherapy. 56:110-111
Publikováno v:
Therapeutic Drug Monitoring. 38:628-633
BACKGROUND Pregabalin has been used for the treatment of pain. A clinically accepted method applied to patients with pain has not been published for the determination of pregabalin in human plasma. This study developed a fluorometric ultrahigh-perfor
Publikováno v:
Biological & Pharmaceutical Bulletin. 38:1496-1503
Metabolic saturation of voriconazole based on the trough plasma concentrations of voriconazole and its major metabolite N-oxide were evaluated according to CYP2C19 genotypes in 58 Japanese patients receiving voriconazole (median dose; 200 mg twice da
Publikováno v:
Therapeutic Drug Monitoring; Oct2019, Vol. 41 Issue 5, p591-597, 7p
Autor:
Takayuki Watanabe, Hiroshi Yamada, Tatsuya Yagi, Yasuaki Mino, Takahiro Yamada, Takafumi Naito, Junichi Kawakami
Publikováno v:
Clinica Chimica Acta. 415:128-132
The pharmacokinetic variability of hydroxy-itraconazole (OH-ITZ), an active metabolite of itraconazole (ITZ), is not fully known.Oral solution of ITZ was administered in 46 immunocompromised patients as a single 200 mg dose for at least 12 days. The